SCHEMBL472956

SCHEMBL472956

CCCCCC=C[Si](OC)(OC)OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.41
TRPV1 Q8NER1 2/20 0.41
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.39
LPAR3 Q9UBY5 1/20 0.37
MAPT P10636 2/20 0.37
MEN1 O00255 1/20 0.37
PLA2G4A P47712 1/20 0.37
PAFAH1B2 P68402 1/20 0.37
KMT2A Q03164 1/20 0.37
MGLL Q99685 1/20 0.37
ABHD6 Q9BV23 1/20 0.37
GMNN O75496 1/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 1/20 0.36
APEX1 P27695 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL472955 1.00 FAAH (0.41) FAAHTRPV1ALDH1A1TSHRLPAR3
SCHEMBL11335872 0.98 FAAH (0.45) FAAHTRPV1MAPTMEN1KMT2A
SCHEMBL472957 0.98 FAAH (0.45) FAAHTRPV1MAPTMEN1KMT2A
SCHEMBL3483168 0.98 FAAH (0.45) FAAHTRPV1MAPTMEN1KMT2A
SCHEMBL18864238 0.98 FAAH (0.45) FAAHTRPV1MAPTMEN1KMT2A
SCHEMBL18864237 0.98 FAAH (0.45) FAAHTRPV1MAPTMEN1KMT2A
SCHEMBL472959 0.98 FAAH (0.45) FAAHTRPV1MAPTMEN1KMT2A
SCHEMBL2803879 0.98 FAAH (0.45) FAAHTRPV1MAPTMEN1KMT2A
SCHEMBL15189564 0.98 FAAH (0.45) FAAHTRPV1MAPTMEN1KMT2A
SCHEMBL15189565 0.98 FAAH (0.45) FAAHTRPV1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2782951-B1 LOW CHLORIDE COMPOSITIONS OF OLEFINICALLY FUNCTIONALISED SILOXANE OLIGOMERS BASED ON ALKOXYSILANES EVONIK DEGUSSA GMBH (DE) 2019-01-02 EP claimed
EP-2782953-B1 COMPOSITION OF OLEFINICALLY FUNCTIONALSIED SILOXANE OLIGOMERS BASED ON ALKOXY SILANES EVONIK DEGUSSA GMBH (DE) 2018-07-25 EP claimed
US-9828392-B2 Low chloride compositions of olefinically functionalised siloxane oligomers based on alkoxysilanes EVONIK DEGUSSA GMBH (DE) 2017-11-28 US claimed
US-9296766-B2 Mixtures, particularly low in volatile organic compounds (VOC), of olefinically functionalised siloxane oligomers based O alkoxy silanes EVONIK DEGUSSA GMBH (DE) 2016-03-29 US claimed
US-9273186-B2 Composition of olefinically functionalised siloxane oligomers based on alkoxy silanes EVONIK DEGUSSA GMBH (DE) 2016-03-01 US claimed
EP-2782952-B1 MIXTURES, PARTICULARLY LOW IN VOLATILE ORGANIC COMPOUNDS (VOC), OF OLEFINICALLY FUNTIONALISED SILOXANE OLIGOMERS BASED ON ALKOXY SILANES EVONIK DEGUSSA GMBH (DE) 2015-09-09 EP claimed
US-20150080531-A1 MIXTURES, PARTICULARLY LOW IN VOLATILE ORGANIC COMPOUNDS (VOC), OF OLEFINICALLY FUNCTIONALISED SILOXANE OLIGOMERS BASED O ALKOXY SILANES EVONIK DEGUSSA GMBH (DE) 2015-03-19 US claimed
US-20140309447-A1 COMPOSITION OF OLEFINICALLY FUNCTIONALISED SILOXANE OLIGOMERS BASED ON ALKOXY SILANES EVONIK DEGUSSA GMBH (DE) 2014-10-16 US claimed
US-20140296555-A1 LOW CHLORIDE COMPOSITIONS OF OLEFINICALLY FUNCTIONALISED SILOXANE OLIGOMERS BASED ON ALKOXYSILANES EVONIK DEGUSSA GMBH (DE) 2014-10-02 US claimed
EP-2782953-A1 COMPOSITION OF OLEFINICALLY FUNCTIONALSIED SILOXANE OLIGOMERS BASED ON ALKOXY SILANES Evonik Degussa GmbH (DE) 2014-10-01 EP claimed
EP-2782951-A1 LOW CHLORIDE COMPOSITIONS OF OLEFINICALLY FUNCTIONALISED SILOXANE OLIGOMERS BASED ON ALKOXYSILANES Evonik Degussa GmbH (DE) 2014-10-01 EP claimed
EP-2782952-A1 MIXTURES, PARTICULARLY LOW IN VOLATILE ORGANIC COMPOUNDS (VOC), OF OLEFINICALLY FUNTIONALISED SILOXANE OLIGOMERS BASED ON ALKOXY SILANES Evonik Degussa GmbH (DE) 2014-10-01 EP claimed
US-20140102332-A1 FUNCTIONAL REINFORCING FILLERS MODIFIED WITH ALKENYLALKOXYSILANE AND PREPARING METHOD OF THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-04-17 US claimed
WO-2013076035-A1 MIXTURES, PARTICULARLY LOW IN VOLATILE ORGANIC COMPOUNDS (VOC), OF OLEFINICALLY FUNTIONALISED SILOXANE OLIGOMERS BASED ON ALKOXY SILANES EVONIK DEGUSSA GMBH (DE) 2013-05-30 WO claimed
WO-2013076036-A1 COMPOSITION OF OLEFINICALLY FUNCTIONALSIED SILOXANE OLIGOMERS BASED ON ALKOXY SILANES EVONIK DEGUSSA GMBH (DE) 2013-05-30 WO claimed
WO-2013076032-A1 LOW CHLORIDE COMPOSITIONS OF OLEFINICALLY FUNCTIONALISED SILOXANE OLIGOMERS BASED ON ALKOXYSILANES EVONIK DEGUSSA GMBH (DE) 2013-05-30 WO claimed
EP-4501441-A1 ORGANIC-INORGANIC HYBRID MEMBRANE, ORGANIC-INORGANIC HYBRID MEMBRANE COMPOSITE, GAS SEPARATION AND CONCENTRATION METHOD, GAS SEPARATION MEMBRANE MODULE, METHOD FOR PRODUCING ORGANIC-INORGANIC HYBRID MEMBRANE, AND METHOD FOR PRODUCING ORGANIC-INORGANIC HYBRID MEMBRANE COMPOSITE Mitsubishi Chemical Corporation (JP) 2025-02-05 EP disclosed
WO-2025023143-A1 GLASS CLOTH TREATMENT LIQUID AND SURFACE TREATED GLASS CLOTH 信越化学工業株式会社 2025-01-30 WO disclosed
EP-2223973-A1 Metal oxide fine particles, silicone resin composition and use thereof Nitto Denko Corporation (JP) 2010-09-01 EP disclosed
US-20100213415-A1 METAL OXIDE FINE PARTICLES, SILICONE RESIN COMPOSITION AND USE THEREOF NITTO DENKO CORPORATION (JP) 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140102332-A1 FUNCTIONAL REINFORCING FILLERS MODIFIED WITH ALKENYLALKOXYSILANE AND PREPARING METHOD OF THE SAME TST, MSN, TELO2 FAAH 424/4885TRPV1 2927/4885ALDH1A1 993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.